DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder

Information source: AstraZeneca
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Bipolar I Disorder

Intervention: quetiapine fumarate (Drug); lithium (Drug); divalproex (Drug)

Phase: Phase 3

Status: Completed

Sponsored by: AstraZeneca

Official(s) and/or principal investigator(s):
AstraZeneca Seroquel Medical Science Director, MD, Study Director, Affiliation: AstraZeneca

Summary

The purpose of this study is to determine whether quetiapine when used as adjunct to lithium or divalproex is safe and effective in the maintenance treatment of adult patients with Bipolar I Disorder. The study consists of enrollment and 2 phases, the Open-label treatment Phase and the Randomized treatment Phase.

Clinical Details

Official title: A Multicenter, Randomized, Parallel-Group, Double-Blind, Phase 3 Comparison of the Efficacy & Safety of Quetiapine Fumarate to Placebo When Used as Adjunct to Mood Stabilizers (Lithium or Valproate) in the Maintenance Treatment of Bipolar I Disorder in Adult Patients (Abbreviated)

Study design: Prevention, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study

Primary outcome: Evaluate the efficacy of quetiapine versus placebo when used as adjunct therapy to mood stabilizer in increasing time to recurrence of a mood event.

Secondary outcome: Evaluate the efficacy of quetiapine versus placebo when used as a adjunct therapy to mod stabilizer in increasing time to recurrence of a manic event

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- A diagnosis of Bipolar I Disorder, Most recent episode Manic (296. 4x), or Bipolar I

Disorder, Most Recent Episode Depressed (296. 5x), or Bipolar I Disorder, Most recent Episode Mixed (296. 6x), with or without psychotic features, as defined by Diagnostic

and Statistical Manual of Mental Disorders - Fourth Edition (DSM-IV)

- At least 1 manic, depressed, or mixed episode in the 2 years prior to the index

episode.

- Able to understand and comply with the requirements of the study.

Exclusion Criteria:

- Diagnosis of an anxiety disorder as defined by DSM-IV, which was treated with

medication within the past year.

- Known intolerance or lack of response to quetiapine fumarate or to the assigned mood

stabilizer, as judged by the investigator.

- Previously randomized into this study or D1447C00126

Locations and Contacts

Research Site, Assebroek, Belgium

Research Site, Brussels, Belgium

Research Site, Gent, Belgium

Research Site, Kortenberg, Belgium

Research Site, Manage, Belgium

Research Site, St-Denijs-Westrem, Belgium

Research Site, Waregem, Belgium

Research Site, Kardjali, Bulgaria

Research Site, Rousse, Bulgaria

Research Site, Sofia, Bulgaria

Research Site, Varna, Bulgaria

Research Site, Jeseník, Czech Republic

Research Site, Litomolice, Czech Republic

Research Site, Olomouc, Czech Republic

Research Site, Pterova, Czech Republic

Research Site, Praha 10, Czech Republic

Research Site, Praha 2, Czech Republic

Research Site, Praha 6, Czech Republic

Research Site, Praha 8, Czech Republic

Research Site, Espoo, Finland

Research Site, Harjavalta, Finland

Research Site, Helsinki, Finland

Research Site, Kellokoski, Finland

Research Site, Seinajoki, Finland

Research Site, MARSEILLE CEDEX 9, France

Research Site, BESANCON, France

Research Site, BOURG EN BRESSE, France

Research Site, LA ROCHELLE CEDEX 1, France

Research Site, MONTPELLIER, France

Research Site, PARIS CEDEX 12, France

Research Site, STRASBOURG CEDEX, France

Research Site, NIMES Cedex 4, France

Research Site, TOULOUSE, France

Research Site, Regensburg, Germany

Research Site, Berlin, Germany

Research Site, Köln, Germany

Research Site, München, Germany

Research Site, Saarbrucken, Germany

Research Site, Augsburg, Germany

Research Site, Heidelberg, Germany

Research Site, Homburg, Germany

Research Site, Budapest, Hungary

Research Site, Fuzesabony, Hungary

Research Site, Gyor, Hungary

Research Site, Kecskemet, Hungary

Research Site, Kistarcsa, Hungary

Research Site, Pecs, Hungary

Research Site, Bari, Italy

Research Site, Bergamo, Italy

Research Site, Brescia, Italy

Research Site, CAGLIARI, Italy

Research Site, Civitanova Marche, Italy

Research Site, Milano, Italy

Research Site, Napoli, Italy

Research Site, Padova, Italy

Research Site, Pisa, Italy

Research Site, ROMA, Italy

Research Site, Siena, Italy

Research Site, La Spezia, Italy

Research Site, TRIESTE, Italy

Research Site, FIRENZE, Italy

Research Site, Genova, Italy

Research Site, Bergen, Norway

Research Site, Bodo, Norway

Research Site, BRYNE, Norway

Research Site, NAMSOS, Norway

Research Site, Oslo, Norway

Research Site, OTTESTAD, Norway

Research Site, Skien, Norway

Research Site, Bialystok, Poland

Research Site, Choroszcz, Poland

Research Site, Bydgoszcz, Poland

Research Site, Gdansk, Poland

Research Site, Gorlice, Poland

Research Site, Janów Lubelski, Poland

Research Site, Krakow, Poland

Research Site, Lipno, Poland

Research Site, Lodz, Poland

Research Site, Lublin, Poland

Research Site, Nowy Targ, Poland

Research Site, Poznan, Poland

Research Site, Starogard Gdanski, Poland

Research Site, Szczecin, Poland

Research Site, Torun, Poland

Research Site, Warszawa, Poland

Research Site, Zubki, Poland

Research Site, Moscow, Russian Federation

Research Site, Saratov, Russian Federation

Research Site, St. Petersburg, Russian Federation

Research Site, Johannesburg, South Africa

Research Site, Durban, South Africa

Research Site, Krugersdorp, South Africa

Research Site, Pretoria, South Africa

Research Site, Bloemfontein, South Africa

Research Site, Santiago de Compostela, Spain

Research Site, Bilbao, Spain

Research Site, Vigo, Spain

Research Site, Guadalajara, Spain

Research Site, Barcelona, Spain

Research Site, Granada, Spain

Research Site, Madrid, Spain

Research Site, Oviedo, Spain

Research Site, Sevilla, Spain

Research Site, Falkoping, Sweden

Research Site, LINKÖPING, Sweden

Research Site, Ludvika, Sweden

Research Site, LUDVIKA, Sweden

Research Site, Sollentuna, Sweden

Research Site, Stockholm, Sweden

Research Site, Sundsvall, Sweden

Research Site, Istanbul, Turkey

Research Site, Adana, Turkey

Research Site, Ankara, Turkey

Research Site, Izmir, Turkey

Research Site, Runcorn, United Kingdom

Research Site, Welwyn Garden City, United Kingdom

Research Site, Birmingham, United Kingdom

Research Site, London, United Kingdom

Research Site, Oxford, United Kingdom

Research Site, Ryhope, United Kingdom

Research Site, Surbiton, United Kingdom

Research Site, Birmingham, Alabama, United States

Research Site, Oviedo, Asturias, Spain

Research Site, Sama de Langreo, Asturias, Spain

Research Site, Terrassa, Barcelona, Spain

Research Site, San Francisco, California, United States

Research Site, Santa Ana, California, United States

Research Site, Redlands, California, United States

Research Site, Chula Vista, California, United States

Research Site, Beverly Hills, California, United States

Research Site, Puerto Real, Cádiz, Spain

Research Site, Miami, Florida, United States

Research Site, Sarasota, Florida, United States

Research Site, Jacksonville, Florida, United States

Research Site, Gainesville, Florida, United States

Research Site, Winter Park, Florida, United States

Research Site, Tampa, Florida, United States

Research Site, Granite City, Illinois, United States

Research Site, Schaumburg, Illinois, United States

Research Site, Libertyville, Illinois, United States

Research Site, Wichita, Kansas, United States

Research Site, Metairie, Louisiana, United States

Research Site, Glen Burnie, Maryland, United States

Research Site, Kalamazoo, Michigan, United States

Research Site, St. Charles, Missouri, United States

Research Site, St. Louis, Missouri, United States

Research Site, Greenwich, New South Wales, Australia

Research Site, Rochester, New York, United States

Research Site, Olean, New York, United States

Research Site, Brooklyn, New York, United States

Research Site, Morganton, North Carolina, United States

Research Site, Raleigh, North Carolina, United States

Research Site, Oklahoma City, Oklahoma, United States

Research Site, Portland, Oregon, United States

Research Site, Philadelphia, Pennsylvania, United States

Research Site, Havertown, Pennsylvania, United States

Research Site, Media, Pennsylvania, United States

Research Site, Everton Park, Queensland, Australia

Research Site, Southport, Queensland, Australia

Research Site, Brisbane, Queensland, Australia

Research Site, Glenside, South Australia, Australia

Research Site, Houston, Texas, United States

Research Site, Conroe, Texas, United States

Research Site, Box Hill, Victoria, Australia

Research Site, Dandenong, Victoria, Australia

Research Site, Epping, Victoria, Australia

Research Site, Richmond, Victoria, Australia

Research Site, Richmond, Virginia, United States

Research Site, Seattle, Washington, United States

Research Site, Milwaukee, Wisconsin, United States

Additional Information

Starting date: April 2004
Last updated: October 3, 2007

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009